Human monocyte colony-stimulating factor enhances the clearance of lipoproteins containing apolipoprotein B-100 via both low density lipoprotein receptor-dependent and -independent pathways in rabbits.
To investigate the effects of recombinant human monocyte colony-stimulating factor (M-CSF) on plasma cholesterol metabolism, we injected M-CSF intravenously into New Zealand White rabbits (n = 13) at a dose of 100 micrograms/day for 7 days. After the treatment, the plasma cholesterol levels fell by 33.2% from 61.4 +/- 25.9 to 41.0 +/- 10.2 mg/dl (mean +/- S.D.). We also injected a large dose of M-CSF (500 micrograms/day) for 6 days into Watanabe Heritable Hyperlipidemic rabbits, which are deficient in low density lipoprotein (LDL) receptors. Again, there was a significant reduction in plasma cholesterol levels by 36.2% from 730.5 +/- 176.4 to 466.0 +/- 104.9 mg/dl (n = 4). In the kinetic studies in New Zealand White rabbits with very low density lipoprotein, LDL, and methylated LDL, the removal rates of those lipoproteins were increased 1.9-, 1.7-, and 2.0-fold, respectively, after the treatment. Immunoblot analysis of LDL receptors in the treated rabbits showed no significant changes in LDL receptor proteins in livers but a great increase in spleens and bone marrows compared with the controls. Messenger RNA was also estimated by Northern blotting in both groups, and the results were compatible with those from the immunoblot. The data suggest that M-CSF stimulates the clearance of lipoproteins containing apolipoprotein B-100 via both LDL receptor-dependent and -independent pathways in target cells of M-CSF and reduces plasma cholesterol.
Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.
H
H
Shimano
N
N
Yamada
S
S
Ishibashi
K
K
Harada
A
A
Matsumoto
N
N
Mori
T
T
Inaba
K
K
Motoyoshi
H
H
Itakura
F
F
Takaku
D000818:Animals; D053299:Apolipoprotein B-100; D001055:Apolipoproteins B / Q000378:metabolism*; D001057:Apolipoproteins E / Q000235:genetics; D002118:Calcium / Q000378:metabolism; D002784:Cholesterol / Q000097:blood; D003115:Colony-Stimulating Factors / Q000494:pharmacology*; D006801:Humans; D006949:Hyperlipidemias / Q000378:metabolism; D007700:Kinetics; D008074:Lipoproteins / Q000097:blood / Q000378:metabolism*; D016173:Macrophage Colony-Stimulating Factor; D008297:Male; D008970:Molecular Weight; D012333:RNA, Messenger / Q000187:drug effects / Q000235:genetics; D011817:Rabbits; D011973:Receptors, LDL / Q000187:drug effects / Q000378:metabolism*; D011994:Recombinant Proteins / Q000494:pharmacology; D012016:Reference Values; D013997:Time Factors; D014280:Triglycerides / Q000097:blood
D053299:Apolipoprotein B-100; D001055:Apolipoproteins B; D001057:Apolipoproteins E; D003115:Colony-Stimulating Factors; D008074:Lipoproteins; D012333:RNA, Messenger; D011973:Receptors, LDL; D011994:Recombinant Proteins; D014280:Triglycerides; D016173:Macrophage Colony-Stimulating Factor; D002784:Cholesterol; D002118:Calcium